H. Friess et al., CRIPTO, A MEMBER OF THE EPIDERMAL GROWTH-FACTOR FAMILY, IS OVER-EXPRESSED IN HUMAN PANCREATIC-CANCER AND CHRONIC-PANCREATITIS, International journal of cancer, 56(5), 1994, pp. 668-674
Cripto is a 188 amino-acid protein containing a central segment that s
hares amino-acid sequence homology with epidermal growth factor (EGF)
and transforming growth factor alpha (TGF-alpha). The EGF receptor, EG
F and TGF-alpha are expressed in the normal human pancreas, and are ov
er-expressed in human pancreatic cancer. Therefore, in the present stu
dy we sought to determine wheather cripto is found in the normal human
pancreas and whether its expression is altered in pancreatic cancer.
Because chronic pancreatitis (CP) is associated with interstitial fibr
osis similar to that observed in pancreatic cancer, we also examined c
ripto expression in pancreatic tissues from patients with CP. In the n
ormal pancreas, cripto immunoreactivity was found at moderate levels i
n most ductal cells and was present very faintly in a rare acinar cell
. In 26 of 58 pancreatic cancers, cripto immunoreactivity was present
in many cancer cells. Its presence was associated with advanced tumor
stage, but not with shorter post-operative survival. Cripto was also p
resent in acinar and ductal cells adjacent to the cancer cells, and in
many ductal and atrophic acinar cells in the CP samples. Northern blo
t analysis revealed a marked increase in cripto mRNA levels in the can
cer and CP samples. By densitometry, there was a 11- and 4-fold increa
se in cripto mRNA levels in pancreatic cancer and CP respectively. Sou
thern blot analysis did not reveal an increase in gene copies encoding
cripto either in cancer or in CP. These findings indicate that cripto
expression may contribute to disease progression in pancreatic cancer
, and implicate cripto in the histopathological alterations that occur
in the pancreas both in cancer and in CP. (C) 1994 Wiley-Liss, Inc.